CHMCHIMERIC THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 21 Aug 2026, 22:45 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 19 Aug 2026, 19:08 | CHM ceases enrolment in Phase 1 trial and Company update | Company Update | MS | 03027, 09014, 11001 | |
| 17 Aug 2026, 19:53 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 7 Aug 2026, 22:04 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 1 Aug 2026, 01:03 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 30 July 2026, 00:10 | Chimeric receives $1.62M advance on FY26 R&D tax incentive | Capital Raising | MS | 03022, 11001 | |
| 28 July 2026, 21:19 | Investor Presentation | Presentations | — | 03026 | |
| 23 July 2026, 02:50 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 18 July 2026, 03:26 | Notification regarding unquoted securities - CHM | Other | — | 06021 | |
| 18 July 2026, 03:25 | Notification regarding unquoted securities - CHM | Other | — | 06021 | |
| 16 July 2026, 19:04 | CHM CDH17 Phase 1 clinical trial update - New DL 3 data | Company Update | MS | 11001 | |
| 15 July 2026, 03:11 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 15 July 2026, 02:28 | Notification of cessation of securities - CHM | Other | — | 06027 | |
| 8 July 2026, 00:41 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 6 July 2026, 19:01 | Board Update | Company Administration | — | 12001 | |
| 3 July 2026, 02:24 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 1 July 2026, 19:01 | Appointment of Financial Adviser for Strategic Review | Company Update | MS | 11001 | |
| 12 June 2026, 03:08 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 2 June 2026, 02:52 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 1 June 2026, 18:27 | CHM announces positive Phase 1/2 data at ASCO | Company Update | MS | 11001 | |
| 21 May 2026, 03:09 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 13 May 2026, 03:32 | Notice under section 708A | Securities Administration | — | 06018 | |
| 13 May 2026, 03:25 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 13 May 2026, 03:20 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 9 May 2026, 03:33 | Proposed issue of securities - CHM | Securities Administration | — | 06013 | |
| 6 May 2026, 03:02 | Notification of cessation of securities - CHM | Other | — | 06027 | |
| 6 May 2026, 00:07 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 5 May 2026, 02:45 | Notification regarding unquoted securities - CHM | Other | — | 06021 | |
| 5 May 2026, 02:25 | Notice under section 708A | Securities Administration | — | 06018 | |
| 5 May 2026, 02:20 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 2 May 2026, 03:30 | Application for quotation of securities - CHM | Other | — | 06020 | |
| 30 Apr 2026, 21:40 | Notification regarding unquoted securities - CHM | Other | — | 06021 | |
| 30 Apr 2026, 21:25 | Notification regarding unquoted securities - CHM | Other | — | 06021 | |
| 30 Apr 2026, 01:41 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 29 Apr 2026, 19:30 | Capital Consolidation Complete | Securities Administration | — | 06005, 06007 | |
| 29 Apr 2026, 19:23 | Update - Consolidation/Split - CHM | Securities Administration | — | 06005, 06007 | |
| 27 Apr 2026, 19:15 | CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi | Company Update | MS | 11001 | |
| 17 Apr 2026, 22:34 | Update - Consolidation/Split - CHM | Securities Administration | — | 06005, 06007 | |
| 17 Apr 2026, 22:22 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 10 Apr 2026, 02:28 | Notification of cessation of securities - CHM | Other | — | 06027 | |
| 25 Mar 2026, 21:07 | Investor presentation | Presentations | — | 03026 | |
| 23 Mar 2026, 23:08 | Chimeric to present at NWR Virtual Healthcare Conference | Company Administration | — | 12008 | |
| 23 Mar 2026, 19:25 | Prospectus | Securities Administration | — | 06009, 06010 | |
| 19 Mar 2026, 19:34 | Update - Proposed issue of securities - CHM | Securities Administration | — | 06013 | |
| 19 Mar 2026, 19:26 | Consolidation/Split - CHM | Securities Administration | MS | 06005, 06007 | |
| 19 Mar 2026, 19:21 | Notice of Extraordinary General Meeting/Proxy Form | Meetings & Governance | — | 08002, 08004 | |
| 6 Mar 2026, 21:20 | Letter to Shareholders | Letters & Addresses | — | 16002 | |
| 2 Mar 2026, 21:01 | Chimeric receives $1.8 M advance on FY26 R&D tax incentive | Periodic Reports | MS | 03014, 12008 | |
| 28 Feb 2026, 03:19 | Half Year Report and Appendix 4D 31 December 2025 | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 27 Feb 2026, 20:08 | Portfolio streamlined - return of CHM CLTX to City of Hope | Company Update | MS | 11001 |
1–50 of 95
1 / 2